secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2026-02-27T23:59:59+00:00
Accession:  0001193125-26-077646
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar Therapeutics prices 20M share public offering at $5.00 per share; underwriters exercise over-allotment
--------------------------------------------------------------------------------

- Offering of 20,000,000 shares plus 3,000,000 over-allotment shares at $5.00 per share.
- Net proceeds after underwriting discounts and expenses expected to be approx. $107.6M.
- Underwriters include J.P. Morgan, Guggenheim, LifeSci Capital, William Blair, and others.
- Offering expected to close on February 27, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000119312526077646/0001193125-26-077646-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000119312526077646/d120172d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-077646

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer